Overview of the RaDaR Registry and
Implications of IgA Nephropathy Management
Learn about the recent data from the RaDar Registry and the
potential impact they will have on IgA Nephropathy
management
A retrospective cohort study describing long-term outcomes in a large cohort of patients with IgA Nephropathy was recently published in Clinical Journal of the American Society of Nephrology. Investigators collected data from nearly 2500 patients enrolled in the UK RaDaR registry to help elucidate disease progression in patients with IgA nephropathy and to determine lifetime risk of kidney failure.1 Tune in and listen to Dr. Brad Rovin and Dr. Shikha Wadhwani discuss these important findings and their potential implications on clinical practice and patient management.
00:36:46
References: 1. Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-Term Outcomes in IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 2023 Apr 13; https://doi.org/10.2215/CJN.0000000000000135.